Latest News Releases

Updates every hour. Last Updated: 11-Sep-2025 17:11 ET (11-Sep-2025 21:11 GMT/UTC)

27-Apr-2025

A topical BRAF-inhibiting gel may mitigate acneiform rash in patients receiving EGFR-targeted therapy for colorectal cancer

American Association for Cancer Research
Reports and Proceedings

27-Apr-2025

AACR: First-in-class covalent Werner helicase inhibitor shows clinical proof-of-concept in Phase I trial

University of Texas M. D. Anderson Cancer Center
Reports and Proceedings

27-Apr-2025

AACR: Topical gel relieves painful skin rash side effect caused by targeted therapy for colorectal cancer

University of Texas M. D. Anderson Cancer Center
Reports and Proceedings

27-Apr-2025

AACR: Topical treatment offers relief from painful skin rash caused by targeted cancer therapy

University of California - Los Angeles Health Sciences
Reports and Proceedings

27-Apr-2025

AI-driven biomarker model may improve detection of cancer cachexia

American Association for Cancer Research
Reports and Proceedings

27-Apr-2025

Pretrained machine learning models may help accurately diagnose nonmelanoma skin cancer in resource-limited settings

American Association for Cancer Research
Reports and Proceedings

27-Apr-2025

AACR: Olaparib and pembrolizumab combination shows early promise in molecularly selected, tumor-agnostic trial

University of Texas M. D. Anderson Cancer Center
Reports and Proceedings

27-Apr-2025

Moffitt study uncovers a way to boost treatment for aggressive melanoma

H. Lee Moffitt Cancer Center & Research Institute
Peer-Reviewed Publication

27-Apr-2025

Adding perioperative pembrolizumab to standard of care improves outcomes in patients with newly diagnosed head and neck cancer

American Association for Cancer Research
Reports and Proceedings

27-Apr-2025

Immunotherapy improves survival of patients with locally advanced head and neck cancer

WashU Medicine
Reports and Proceedings